Changzhou Sunlight Pharmaceutical (Sunlight Pharma) is located in Benniu town, Changzhou city, Jiangsu province, China. It is close to the Beijing-Shanghai High-Speed Railway, Shanghai-Nanjing Expressway, and Changzhou Airport via convenient transportation. Sunlight Pharma was founded in 1990 and covers a total area of 369,580m². Sunlight Pharma has four production sites, and they are Changzhou site, Yancheng site, Dalian site and Lijin site. Changzhou site produces pharmaceutical formulations, APIs, and pharmaceutical intermediates; Yancheng site is located in Jiangsu Costal Industrial Park and it mainly produces pharmaceutical intermediates, specialty chemicals and also provides CMO service; Dalian site is located in Economic Development Zone of Changxing Island, Dalian city, where mainly produces polyimide monomers, pharmaceutical intermediates, and provides CMO service. Lijin site is located in Dongying City, Shangdong Province, where mainly produces pharmaceutical intermediates, specialty chemicals and provides CMO service. 
Sunlight Pharma is a National High-tech Enterprise consisting of the R&D, manufacturing and sales. It is a Safety Production Standardization Secondary Enterprise, Specialized and Sophisticated Enterprise which produces new and unique products in Jiangsu province, Jiangsu AAA Credit Enterprise Outstanding Scientific and Technological Enterprise. It is also recognized as a progressive and environmental-friendly company. The company has already been certified with the ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, and ISO 45001:2018 Occupational Health and Safety Management System, as well as passed with GB/T 29490-2023 Certification of Enterprise Intellectual Property Compliance Management System. Sunlight Pharma has already obtained the Chinese Drug Manufacturing License which allows the company to produce pharmaceutical chemical intermediates, APIs and finished products. With 80% of our products being exported to international markets such as the USA, Europe, and Southeast Asia, Sunlight Pharma has built a steady cooperative relationship with hundreds of clients, including top 500 enterprises. We have already pass the audits by EDQM, USFDA, NMPA and Japan PMDA for our APIs and have gotten both the COS certificate and EU GMP certificate. 
Sunlight Pharma currently has over 1000 employees, including some foreign experts, and graduates from Universities in Europe, America, Russia, Japan, Korea and India. Our R&D center has an excellent R&D team which is composed of PhDs, professors and senior engineers. We have already obtained 186 patents in China. We have the leading technology of Catalytic Hydrogenation, Nitration Reaction, Oxidation Reaction, Reductive Alkylations, Chiral Resolution, and Cryogenic Reaction in China. Our Formulation R&D Laboratory is equipped with advance instruments, which can fulfil the R&D tasks for both general solid dosage forms and sustained-and-controlled release solid dosage forms. 
Sunlight Pharma owns modern manufacturing workshops for APIs and Oral Solid Formulations, which are designed and constructed in accordance with the national safety standards and GMP requirements. The API workshop is fully equipped with reactors with volume ranging from 100L to 6000L, temperature ranging from -78℃ to 300℃, and pressure up to 12.5MPa. The Oral Solid Formulation Workshop is equipped with granulation linkage lines, fully automatic clean air conditioning system, and a purified water preparation system. It can produce tablets, capsules, and granules simultaneously to meet customers’demands for custom-manufactured products. 
Our R&D and QC center are equipped with advanced analytical instruments and equipment, which are imported from America and Japan, including ICP-MS, LC-MS, GC-MS, GC, HPLC, UPLC, FT-IR, UV/VIS, AA, Malvern Laser Particle Size Analyzer, Automatic Moisture Analyzer, Titrator, Drug Stability Test Chamber. 
Our modern warehouses of raw materials and finished products is managed under the ERP management system. We also have a dedicated warehouse controlling the temperature and humidity at storage. Sunlight Pharma has the highest commitments for environmental protection. We have already built two 8500m³ waste water treatment and purifying sites, so as to guarantee the company’s sustainable development and provide stable service to our customers. 
Sunlight Pharma committed ourselves to “Create benefits for customers, Create prosperity for society, Create future for employees, Create value for shareholders, Create happiness for human beings”. With the philosophy of “Quality, Service and Reputation First”, we will continuously provide the highest quality products and service for both our clients and society.